Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus

World Journal of Pediatrics

Volumn 16, Issue 3, 2020, Pages 240-246

  Chen, Zhi Min ^a   Fu, Jun Fen ^a   Shu, Qiang ^a   Chen, Ying Hu ^a   Hua, Chun Zhen ^a   Li, Fu Bang ^a   Lin, Ru ^a   Tang, Lan Fang ^a   Wang, Tian Lin ^a   Wang, Wei ^a   Wang, Ying Shuo ^a   Xu, Wei Ze ^a   Yang, Zi Hao ^a   Ye, Sheng ^a   Yuan, Tian Ming ^a   Zhang, Chen Mei ^a   Zhang, Yuan Yuan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Child; Diagnosis; New coronavirus; Recommendation; Respiratory infection; Treatment

Indexed keywords

ALPHA2B INTERFERON; ANTIBIOTIC AGENT; LOPINAVIR; VASOACTIVE AGENT;

ANAMNESIS; ANTIVIRAL THERAPY; ASSISTED VENTILATION; BACTERIAL PNEUMONIA; BLOOD SAMPLING; CHILD; CLINICAL CLASSIFICATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORONAVIRUS DISEASE 2019; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; EARLY DIAGNOSIS; EARLY INTERVENTION; EXTRACORPOREAL OXYGENATION; FECES ANALYSIS; HEMOFILTRATION; HOSPITAL DISCHARGE; HOSPITAL HYGIENE; HUMAN; IMMUNOTHERAPY; INFECTION CONTROL; ISOLATION; LABORATORY DIAGNOSIS; LABORATORY TEST; LUNG LAVAGE; MYCOPLASMA PNEUMONIA; NEBULIZATION; ONSET AGE; PATIENT MONITORING; PATIENT TRANSPORT; PEDIATRIC PATIENT; REVIEW; SEQUENCE ANALYSIS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SPUTUM ANALYSIS; SUSCEPTIBLE POPULATION; THORAX RADIOGRAPHY; THROAT CULTURE; TRAVEL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VIRUS ETIOLOGY; COMPLICATION; CORONAVIRUS INFECTION; PANDEMIC; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTION; VIROLOGY; VIRUS PNEUMONIA;

CHILD; CORONAVIRUS INFECTIONS; HUMANS; PANDEMICS; PNEUMONIA, VIRAL; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY TRACT INFECTIONS;

EID: 85079228854     PISSN: 17088569     EISSN: 18670687     Source Type: Journal    
DOI: 10.1007/s12519-020-00345-5     Document Type: Review

References (14)

1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, Coronavirus Investigating, and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020. 10.1056/NEJMoa2001017. DOI: 10.1056/NEJMoa2001017
2. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020. 10.1016/S0140-6736(20)30154-9. DOI: 10.1016/S0140-6736(20)30154-9
3. National Recommendations for Diagnosis and Treatment of pneumonia caused by 2019-nCoV (the 4th edition). National Health Commission and National Administrative Office of Chinese Tradition Medicine. https://www.nhc.gov.cn/xcs/zhengcwj/202001/4294563ed35b43209b31739bd0785e67/files/7a9309111267475a99d4306962c8bf78.pdf. Access 29 Jan 2020.
4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. 10.1016/S0140-6736(20)30183-5. DOI: 10.1016/S0140-6736(20)30183-5
5. Stanley P. Another decade, another coronavirus. N Engl J Med. 2019. 10.1056/NEJMe2001126. DOI: 10.1056/NEJMe2001126
6. Ma XJ, Wang LN, Wang LB, Wang XF, Fang F, Deng L, et al. Diangosis and treatment guideline of community acquired pneumonia in children. Chin Clin Infect Dis J. 2019;12:6–13.
7. Chu CM. Role of Lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59:252–6. DOI: 10.1136/thorax.2003.012658
8. Arabi YM, Alothman A, Balkhy HH, Al-Dawood A, AlJohani S, Al Harbi S, et al. Treatment of Middle East respiratory syndrome with a combination of lopinavir–ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials. 2018;19:81. DOI: 10.1186/s13063-017-2427-0
9. Lu Q, Wang XF, Qiang Y, Li XM, Zhang HL, Wang LN, et al. Expert consensus on the diagnosis and treatment of viral pneumonia in children (2019). Zhongguo Shi Yong Er Ke Za Zhi. 2019;34:801–7 (in Chinese).
10. Arabi YM, Mandourah Y, Al-Hameed F, Sindi AA, Almekhlafi GA, Hussein MA, et al. Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med. 2018;197:757–67. DOI: 10.1164/rccm.201706-1172OC
11. WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Jan 11, 2020. https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf?sfvrsn=bc7da517_2. Accessed 30 Jan 30 2020.
12. The Subspecialty Group of Respiratory Diseases, The Editorial Board, Chinese Journal of Pediatrics. Diagnosis and treatment guideline of community acquired pneumonia in children (2013 the First part). Zhonghua Er Ke Za Zhi. 2013;51:745–52.
13. Wang XF, Deng L, Liu JR, Liu CF, Liu EM, Liu HW, et al. Guidelines for the diagnosis and treatment of adenovirus pneumonia in children (2019 edition). Chin J Cli Infect Dis. 2019;12:161–6 (in Chinese).
14. Pediatric Group, Extracorporeal Life Support Committee, Pediatric Critical Physicians Branch, Chinese Medical Association Emergency Group, Pediatric Branch, Chinese Medical Association Thoracic Vascular Anesthesiology Society, Extracorporeal Life Support Committee, Pediatric Surgery Branch, Chinese Medical Association. Consensus of extracorporeal membrane oxygenation support for acute fulminant myocarditis in children. Chin J Emerg Med. 2020;29:5–10 (in Chinese).